TYMS and colorectal carcinoma: TYMS encodes thymidylate synthase, which is the primary target of 5-FU, impairs the drug sensitivity in colorectal carcinoma, and is found to activate aggressive cancer cells (Zhou et al., 2012; Abdallah et al., 2015).